Reports of inaccurate FHR monitoring, including outcomes of stillbirth and low Apgar score, have been reported with the use of the Avalon Fetal Monitor in Canada and internationally. Although Health Canada’s review of the available information found that inaccurate FHR monitoring has been observed in some cases, there was insufficient evidence to establish a link between the use of the Avalon Fetal Monitor and adverse fetal outcome. A review of the literature shows that all continuous FHR monitors that use Doppler ultrasound to derive FHR have the potential to show inaccurate readings.
Products affected
|
Medical Device Licence Name |
Manufacturer |
Medical Device Licence Numbers |
|
Avalon Fetal Monitor FM20 |
Philips Medizin Systeme Boeblingen GmbH |
70451 |
|
Avalon Fetal Monitor FM30 |
Philips Medizin Systeme Boeblingen GmbH |
70452 |
|
Avalon Fetal Monitor FM40 |
Philips Medizin Systeme Boeblingen GmbH |
77190 |
|
Avalon Fetal Monitor FM50 |
Philips Medizin Systeme Boeblingen GmbH |
77094 |
Background information
The Avalon Fetal Monitor is a continuous electronic fetal monitoring device, which uses a cardiotocograph (CTG) to allow healthcare professionals providing obstetrical care to analyze FHR changes during labour and delivery, and to institute timely intervention to avoid intrapartum hypoxic and/or ischemic injury.
The Avalon Fetal Monitor models FM20, FM30, FM40 and FM50 are used for monitoring FHR and MHR in labour and delivery rooms, and in antepartum testing areas. While features vary among the Avalon Fetal Monitor models, all four models have the same device software.
Maternal artefact is common in Doppler ultrasound-derived FHR tracings and is a limitation associated with the use of CTG technology, nonspecific to any particular manufacturer. Many fetal monitors include signal modulation and autocorrelation algorithms, and use wider ultrasound beams to decrease FHR signal loss. However, such features can also increase the likelihood of accidental recording of the MHR. Literature reports suggest that any continuous FHR, from any Fetal monitor that uses Doppler ultrasound for the determination of FHR, could show inaccurate FHR.
The Avalon Fetal Monitor manufacturer initiated a
recall in 2009 to amend the IFU by including an addendum with supplemental information to further help users recognize any potential inaccuracies in the readings and to mitigate risks arising from inaccurate FHR readings or the misinterpretation of tracings. This addendum has since been incorporated into all subsequent versions of the Avalon Fetal Monitor IFU. This recall did not involve product removal from the market.
In 2014, the manufacturer released an updated software version of the Avalon Fetal Monitor. Starting with software Revision J.3, an audible alarm tone with the coincidence alarm is provided to help users identify potential coincidence between all monitored heart rates.
In 2017, Health Canada received incident reports related to the Avalon Fetal Monitor and inaccurate FHR monitoring. As a result, Health Canada conducted a safety review to assess the potential safety risks associated with this device.
At the time of the review, 10 Canadian incident reports had been received by Health Canada for the Avalon Fetal Monitor in which stillbirth or potential need for immediate care at birth were described. Internationally, there were also reports of stillbirth, neonatal death, poor neonatal outcome, and unnecessary caesarean section associated with the use of Avalon Fetal Monitors. While Health Canada found that inaccurate FHR monitoring had occurred in some cases, there was insufficient information in the reports to establish a relationship between the incidents and the use of the Avalon Fetal Monitor. Additionally, Health Canada found no evidence of malfunction of the Avalon Fetal Monitor in the reported incidents.